Expensify And 2 Other Stocks Under $2 Insiders Are Buying
Portfolio Pulse from Avi Kapoor
Insiders at Expensify, Perspective Therapeutics, and Rave Restaurant Group have recently made significant stock purchases. Expensify's 10% owner bought shares at $1.76 each, following a price target increase by Piper Sandler. Perspective Therapeutics' director acquired shares at $0.58 each, with B. Riley Securities initiating coverage with a Buy rating. Rave Restaurant Group's insider purchased shares at $1.96 each after a reported increase in Q4 sales.
January 31, 2024 | 11:31 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Perspective Therapeutics' director bought shares at $0.58, and B. Riley Securities initiated coverage with a Buy rating and a $1.20 price target.
The director's purchase and the initiation of coverage with a Buy rating and a higher price target indicate a positive short-term outlook for Perspective Therapeutics' stock.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90
POSITIVE IMPACT
Expensify's 10% owner purchased shares at $1.76, and Piper Sandler raised the price target from $2 to $3, indicating a positive outlook.
The insider purchase combined with the analyst's increased price target suggests a bullish sentiment for Expensify in the short term, potentially leading to a positive impact on the stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Rave Restaurant Group's insider acquired shares at $1.96 following a reported increase in Q4 sales.
The insider's purchase after a positive sales report for Q4 suggests confidence in the company's performance, which may positively influence Rave Restaurant Group's stock price in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80